BioSyent Schedules Q1 2021 Earnings Release for May 27, 2021
20 May 2021 - 10:00PM
BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be
reporting its financial results for the three months ended March
31, 2021 on Thursday, May 27, 2021 at 8:00am EDT. A presentation on
the Company’s first quarter 2021 results by René Goehrum, BioSyent
President and CEO, will also be available on the Company’s website
on the date of release.
About BioSyent Inc.
Listed on the TSX Venture Exchange under the
trading symbol “RX”, BioSyent is a profitable growth-oriented
specialty pharmaceutical company focused on in-licensing or
acquiring innovative pharmaceutical and other healthcare products
that have been successfully developed, are safe and effective, and
have a proven track record of improving the lives of patients.
BioSyent supports the healthcare professionals that treat these
patients by marketing its products through its community, specialty
and international business units.
As of the date of this press release, the
Company has 12,702,375 common shares outstanding.
For a direct market quote for the TSX Venture
Exchange and other Company financial information please visit
www.tmxmoney.com.
For further information please
contact:
Mr. René C. GoehrumPresident and CEOBioSyent
Inc.E-Mail: investors@biosyent.comPhone: 905-206-0013Web:
www.biosyent.com
Biosyent (TSXV:RX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Biosyent (TSXV:RX)
Historical Stock Chart
From Aug 2023 to Aug 2024